Stockreport
Entrepreneur, Public Company CEO, and Philanthropist Parker H. "Pete" Petit Releases New Book "The Entrepreneur's Dilemma: Should I Take My Company Public?" [Yahoo! Finance]
Last mimedx group, inc earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=213465&p=irol-irhome
launch of his new book, "The Entrepreneur's Dilemma: Should I Take My Company Public?" This compelling first-person account chronicles Petit's thrust into entrepreneurship by the crib death of his infant son. His response to this tragedy led him to the helm of five publicly traded companies over his career. This book also outlines the dramatic events that unfolded during Petit's last tenure as CEO of MiMedx, the 5th fastest-growing public company in 2017, as ranked by Fortune Magazine. In "The Entrepreneur's Dilemma," Pete Petit offers a riveting narrative that delves deep into the challenges he faced while steering MiMedx through tumultuous times. The book provides a close look into Petit's first hand dealings with short sellers and experience in handling an internal company coup. It further details the unprecedented challenges Petit encountered, including his indictment by the Department of Justice via the Southern District Court of New York . This legal battle, according to Petit
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | MDXG | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
MDXG alerts
MDXG alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXG alerts
High impacting MiMedx Group, Inc news events
Weekly update
A roundup of the hottest topics
MDXG
NEWS
NEWS
- MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer [Yahoo! Finance][Yahoo! Finance]
- MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer[GlobeNewswire]
- With 45% ownership, MiMedx Group, Inc. (NASDAQ:MDXG) has piqued the interest of institutional investors [Yahoo! Finance][Yahoo! Finance]
- Wound Biologics Market Global Analysis and Forecast to 2030, Featuring Profiles of AlloSource, LifeNet Health, Smith & Nephew, Sanara MedTech, Mtf Biologics, Becton, Dickinson, MiMedx and TissueTech [Yahoo! Finance][Yahoo! Finance]
- MiMedx Group, Inc. (NASDAQ: MDXG) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.[MarketBeat]
- More
MDXG
SEC Filings
SEC Filings
- 6/7/24 - Form 8-K
- 6/6/24 - Form 4
- 6/6/24 - Form 4
- MDXG's page on the SEC website
- More